These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16547245)

  • 61. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection.
    Goulder PJ; Bunce M; Krausa P; McIntyre K; Crowley S; Morgan B; Edwards A; Giangrande P; Phillips RE; McMichael AJ
    AIDS Res Hum Retroviruses; 1996 Dec; 12(18):1691-8. PubMed ID: 8959245
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.
    Keane NM; Roberts SG; Almeida CA; Krishnan T; Chopra A; Demaine E; Laird R; Tschochner M; Carlson JM; Mallal S; Heckerman D; James I; John M
    Immunol Cell Biol; 2012 Feb; 90(2):224-34. PubMed ID: 21577229
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
    Boon AC; de Mutsert G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2006 Jun; 80(12):6024-32. PubMed ID: 16731941
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV.
    Burrows JM; Wynn KK; Tynan FE; Archbold J; Miles JJ; Bell MJ; Brennan RM; Walker S; McCluskey J; Rossjohn J; Khanna R; Burrows SR
    Eur J Immunol; 2007 Apr; 37(4):946-53. PubMed ID: 17357107
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Prediction and modification analysis of low-affinity HLA-A*0201 restricted CTL epitopes derived from HIV-1 pol antigen].
    Huang YX; Li YH; Zhao Y; Han RX; Liu ZX; Mao ZX; Xue CF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):322-4. PubMed ID: 19351501
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C; Burrows SR; Sculley TB; Moss DJ; Misko IS
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9478-82. PubMed ID: 1719531
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes.
    Pasini E; Caggiari L; Dal Maso L; Martorelli D; Guidoboni M; Vaccher E; Barzan L; Franchin G; Gloghini A; De Re V; Sacchi N; Serraino D; Carbone A; Rosato A; Dolcetti R
    Int J Cancer; 2009 Sep; 125(6):1358-64. PubMed ID: 19536817
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stringent allele/epitope requirements for MART-1/Melan A immunodominance: implications for peptide-based immunotherapy.
    Bettinotti MP; Kim CJ; Lee KH; Roden M; Cormier JN; Panelli M; Parker KK; Marincola FM
    J Immunol; 1998 Jul; 161(2):877-89. PubMed ID: 9670966
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Presentation of available CTL epitopes that induction of cell-mediated immune response against HIV-1 Koran clade B strain using computational technology.
    Park H; Chung YS; Yoon CH; Lee SH; Kim SS; Kang C; Choi BS
    HIV Med; 2016 Jun; 17(6):460-6. PubMed ID: 26471354
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibodies and lentiviruses that specifically recognize a T cell epitope derived from HIV-1 Nef protein and presented by HLA-C.
    Herschhorn A; Marasco WA; Hizi A
    J Immunol; 2010 Dec; 185(12):7623-32. PubMed ID: 21076072
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Crystal structure of suboptimal viral fragments of Epstein Barr Virus Rta peptide-HLA complex that stimulate CD8 T cell response.
    Huan X; Zhuo Z; Xiao Z; Ren EC
    Sci Rep; 2019 Nov; 9(1):16660. PubMed ID: 31723204
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunodominant CD8 T cell response to Epstein-Barr virus.
    Houssaint E; Saulquin X; Scotet E; Bonneville M
    Biomed Pharmacother; 2001 Sep; 55(7):373-80. PubMed ID: 11669500
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees.
    Balla-Jhagjhoorsingh SS; Koopman G; Mooij P; Haaksma TG; Teeuwsen VJ; Bontrop RE; Heeney JL
    J Immunol; 1999 Feb; 162(4):2308-14. PubMed ID: 9973508
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multilayered defense in HLA-B51-associated HIV viral control.
    Zhang Y; Peng Y; Yan H; Xu K; Saito M; Wu H; Chen X; Ranasinghe S; Kuse N; Powell T; Zhao Y; Li W; Zhang X; Feng X; Li N; Leligdowicz A; Xu X; John M; Takiguchi M; McMichael A; Rowland-Jones S; Dong T
    J Immunol; 2011 Jul; 187(2):684-91. PubMed ID: 21670313
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.
    Woodberry T; Suscovich TJ; Henry LM; Davis JK; Frahm N; Walker BD; Scadden DT; Wang F; Brander C
    J Infect Dis; 2005 Nov; 192(9):1513-24. PubMed ID: 16206065
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein.
    Liu J; Wu P; Gao F; Qi J; Kawana-Tachikawa A; Xie J; Vavricka CJ; Iwamoto A; Li T; Gao GF
    J Virol; 2010 Nov; 84(22):11849-57. PubMed ID: 20844028
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.
    Trolle T; McMurtrey CP; Sidney J; Bardet W; Osborn SC; Kaever T; Sette A; Hildebrand WH; Nielsen M; Peters B
    J Immunol; 2016 Feb; 196(4):1480-7. PubMed ID: 26783342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.